Back to Market Feed

Product Information

NORITATE 1% CREAM is a brand product labeled by Bausch Health US LLC, priced at $34.3810 per GM under NDC 00187520260. Its NADAC has been published 343 times since Dec 18, 2013.

FDA first approved this application on Sep 26, 1997.

The High Outlier badge above means this manufacturer's average price in the metronidazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

NORITATE 1% CREAM

metronidazole
$34.3810per GM
High Outlier

Strength

10 mg/60g

NDC

00187520260

Classification

Brand

Dosage Form

CREAM

Route

TOPICAL

Effective Date

9/17/2025

Active Ingredients

METRONIDAZOLE

Approval Type

New Drug (NDA)

FDA Application

NDA020743

FDA Approved

9/26/1997

On Market Since

8/9/2013

Pharmacological Classes

Nitroimidazole Antimicrobial
Nitroimidazoles

Price Statistics

The NADAC for NORITATE 1% CREAM has been published 343 times since Dec 18, 2013, and over the history we have for it it has risen 533.2%. The table below summarizes its recorded NADAC range and movement.

Current price$34.3810 per GM
All-time high$34.3810 (Oct 1, 2025)
All-time low$5.4294 (Dec 18, 2013)
52-week high$34.3810
52-week low$31.2696
Median price$28.5676
Average price$25.1521
Largest weekly change+59.2% (Dec 25, 2013)
Weeks tracked343
Tracking sinceDec 18, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

+9.9%

3Y

+10.4%

5Y

+10.4%

All

+533.2%

Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the metronidazole market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

VANDAZOLE VAGINAL 0.75% GEL
Brand
00245086070•Upsher-Smith Laboratories LLC
$0.3235
per GM
PYLERA 140-125-125 MG CAPSULE
Brand
61269038012•H2-Pharma LLC
$2.4278
per EA
LIKMEZ 500 MG/5 ML SUSPENSION
Brand
71656006675•Saptalis Pharmaceuticals LLC
$2.5999
per ML
LIKMEZ 500 MG/5 ML SUSPENSION
Brand
81033006620•Kesin Pharma Corporation
$2.6093
per ML
LIKMEZ 500 MG/5 ML SUSPENSION
Brand
71656006620•Saptalis Pharmaceuticals LLC
$2.6117
per ML
TINDAMAX 500 MG TABLET
Brand
00178850020•Mission Pharmacal Company
$13.0140
per EA
TINDAMAX 500 MG TABLET
Brand
00178850060•Mission Pharmacal Company
$13.0140
per EA
SOLOSEC 2 GM GRANULE PACKET
Brand
69751040001•Evofem Inc.
$281.5473
per EA

Frequently asked questions

What is the NADAC price of NORITATE 1% CREAM?

The current National Average Drug Acquisition Cost (NADAC) for NORITATE 1% CREAM, manufactured by Bausch Health US LLC, is $34.3810 per GM (NDC 00187520260), effective Oct 1, 2025.

How has the price of NORITATE 1% CREAM changed over time?

Over the history we have for it, the NADAC for NORITATE 1% CREAM has risen 533.2%. It has been tracked across 343 weekly CMS publications since Dec 18, 2013.

What are the highest and lowest recorded NADAC prices for NORITATE 1% CREAM?

Since Dec 18, 2013, the NADAC for NORITATE 1% CREAM has ranged from a low of $5.4294 (Dec 18, 2013) to a high of $34.3810 (Oct 1, 2025), with a median of $28.5676 per GM.

Are there cheaper alternatives to NORITATE 1% CREAM?

No other NADAC-published product currently shares the active ingredient and strength of NORITATE 1% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures NORITATE 1% CREAM?

NORITATE 1% CREAM (NDC 00187520260) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.